In this podcast Dr Ogdie discusses research her team conducted into the treatment burden associated with methotrexate and antitumor necrosis factor inhibitors in both psoriatic arthritis and rheumatoid arthritis, including differences among the 2 patient populations in their perspectives.

In this podcast, Alfred Kim, MD, PhD, and Leonard Calabrese, DO, provide updates on the rapidly changing dynamics of long COVID. They also discuss current strategies in managing the lingering effects after COVID-19 infection among the immunosuppressed population.

In this podcast, Dr Vanessa Kronzer talks about research she and her colleagues conducted into the association of anti-citrullinated protein antibodies with incident rheumatoid arthritis associated interstitial lung disease.

Dr Johnson, assistant professor with the University of Nebraska College of Medicine, discusses a study he and his colleagues conducted into all-cause and cause-specific mortality among veterans with rheumatoid arthritis with and without interstitial lung disease.

Dr Ramiro, from Leiden University Medical Center, Leiden, the Netherlands, reviews changes from the previous guidelines for the management of axial and nonradiographic axial spondyloarthritis from the ASessment in Ankylosing Spondylitis (ASAS)working group.

Dr Paine discusses the findings and implications of a study he and colleagues at the University of Rochester conducted into whether certain metabolic factors indicate a patient's risk of progressing from psoriasis to psoriatic arthritis.